Publicaciones en colaboración con investigadores/as de University of Würzburg (32)

2024

  1. Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases

    Biomimetics, Vol. 9, Núm. 1

  2. Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile

    Neuro-oncology, Vol. 26, Núm. 9, pp. 1723-1737

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

    Clinical Cancer Research, Vol. 29, Núm. 12, pp. 2250-2265

2022

  1. Genomic profiling for clinical decision making in lymphoid neoplasms

    Blood

2021

  1. Additional causal SNRPE mutations in hereditary hypotrichosis simplex

    British Journal of Dermatology

  2. Cereblon enhancer methylation and IMiD resistance in multiple myeloma

    Blood, Vol. 138, Núm. 18, pp. 1721-1726

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial

    European Heart Journal, Vol. 41, Núm. 4, pp. 509-518

2019

  1. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

    Leukemia, Vol. 33, Núm. 1, pp. 159-170

  2. Anisotropic cryostructured collagen scaffolds for efficient delivery of RhBMP-2 and enhanced bone regeneration

    Materials, Vol. 12, Núm. 19

  3. Periosteum-derived mesenchymal progenitor cells in engineered implants promote fracture healing in a critical-size defect rat model

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 13, Núm. 5, pp. 742-752

2018

  1. Tissue Mimicry in Morphology and Composition Promotes Hierarchical Matrix Remodeling of Invading Stem Cells in Osteochondral and Meniscus Scaffolds

    Advanced Materials, Vol. 30, Núm. 28

2017

  1. Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial

    British Journal of Haematology, Vol. 179, Núm. 1, pp. 66-74

2016

  1. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by prior treatment

    Blood, Vol. 127, Núm. 6, pp. 713-721

  2. The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective

    Advances in Therapy, Vol. 33, Núm. 11, pp. 1896-1920

2015

  1. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 8, pp. 1202-1222

  2. Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

    Haematologica, Vol. 100, Núm. 10, pp. 1327-1333

  3. Global myeloma research clusters, output, and citations: A bibliometric mapping and clustering analysis

    PLoS ONE, Vol. 10, Núm. 1

  4. Polymeric electrospun scaffolds: Neuregulin encapsulation and biocompatibility studies in a model of myocardial ischemia

    Tissue Engineering - Part A, Vol. 21, Núm. 9-10, pp. 1654-1661